Molecular prognostication of liver cancer: end of the beginning - PubMed (original) (raw)

Review

. 2006 Apr;44(4):798-805.

doi: 10.1016/j.jhep.2006.01.008. Epub 2006 Feb 7.

Affiliations

• PMID: 16488507
• DOI: 10.1016/j.jhep.2006.01.008

Review

Molecular prognostication of liver cancer: end of the beginning

Snorri S Thorgeirsson et al. J Hepatol. 2006 Apr.

No abstract available

PubMed Disclaimer

Similar articles

• Clinical and molecular classification of hepatocellular carcinoma.
  Llovet JM. Llovet JM. Liver Transpl. 2007 Nov;13(11 Suppl 2):S13-6. doi: 10.1002/lt.21325. Liver Transpl. 2007. PMID: 17969094 Review. No abstract available.
• [The application of gene chip in the diagnosis and treatment of hepatocellular carcinoma].
  Huang W, Yang DH. Huang W, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 May;12(5):317-8. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15161524 Review. Chinese. No abstract available.
• Genetic profiling of human hepatocellular carcinoma.
  Lee JS, Thorgeirsson SS. Lee JS, et al. Semin Liver Dis. 2005;25(2):125-32. doi: 10.1055/s-2005-871192. Semin Liver Dis. 2005. PMID: 15918141 Review.
• Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
  Yoshioka S, Takemasa I, Nagano H, Kittaka N, Noda T, Wada H, Kobayashi S, Marubashi S, Takeda Y, Umeshita K, Dono K, Matsubara K, Monden M. Yoshioka S, et al. Eur J Cancer. 2009 Mar;45(5):881-9. doi: 10.1016/j.ejca.2008.12.019. Epub 2009 Jan 23. Eur J Cancer. 2009. PMID: 19167881
• Molecular classification of hepatocellular carcinoma anno 2011.
  van Malenstein H, van Pelt J, Verslype C. van Malenstein H, et al. Eur J Cancer. 2011 Aug;47(12):1789-97. doi: 10.1016/j.ejca.2011.04.027. Epub 2011 May 24. Eur J Cancer. 2011. PMID: 21612914 Review.

Cited by

• Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer via cell-cell communication.
  Li JT, Zhang HM, Wang W, Wei DQ. Li JT, et al. World J Gastroenterol. 2024 Mar 21;30(11):1609-1620. doi: 10.3748/wjg.v30.i11.1609. World J Gastroenterol. 2024. PMID: 38617448 Free PMC article.
• Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer.
  Jia J, Zhou X, Chu Q. Jia J, et al. Mol Cell Biochem. 2024 Mar 22. doi: 10.1007/s11010-024-04983-5. Online ahead of print. Mol Cell Biochem. 2024. PMID: 38519710 Review.
• Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients.
  Fang F, Wang X, Song T. Fang F, et al. Cancer Biol Med. 2018 Nov;15(4):425-433. doi: 10.20892/j.issn.2095-3941.2018.0027. Cancer Biol Med. 2018. PMID: 30766752 Free PMC article.
• Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agents.
  Lu H, Rogowskyj J, Yu W, Venkatesh A, Khan N, Nakagawa S, Goossens N, Koh AP, Higashi T, Gunasekaran G, Schwarz ME, Hiotis SP, Xu X, Kinney W, Hoshida Y, Block T, Cuconati A, Du Y. Lu H, et al. Bioorg Med Chem Lett. 2016 Dec 1;26(23):5819-5824. doi: 10.1016/j.bmcl.2016.10.015. Epub 2016 Oct 10. Bioorg Med Chem Lett. 2016. PMID: 27793566 Free PMC article.
• Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma.
  Shao J, Meng Q, Li Y. Shao J, et al. Onco Targets Ther. 2016 Jul 14;9:4265-75. doi: 10.2147/OTT.S102858. eCollection 2016. Onco Targets Ther. 2016. PMID: 27478384 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information